← Leaderboards
Jeffrey T Yap
Sarc
$3,544,474
Attributed
$5,743,866
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2012–19$2.5M$1.9M$1.3M$625K$0
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,743,866 · 3
By mechanism
R01$2,932,523 · 1
U54$2,811,343 · 2
Top collaborators
- John M Hoffman5 shared
- Kathryn Ann Morton5 shared
- Rheal A Towner5 shared
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseFutureImageMagnetic Resonance ImagingFunctional DisorderPositron-Emission TomographyDiffusion Magnetic Resonance ImagingMolecularMetabolismTherapeutic AgentsProtocols DocumentationPre-ClinicalResearch Project GrantsSarcomaTranslationsOperative Surgical ProceduresPharmaceutical PreparationsLimb StructureChemotherapyMeasurementMouse ModelNeoadjuvant TherapyDoxorubicinTreatment Response
Grant awards (11)
Causes, consequences, imaging and mitigation of sepsis-induced encephalopathy$581,379
R01 · FY2019 · NS
Preclinical Core$1,478,239
U54 · FY2018 · CA · contact PI
Causes, consequences, imaging and mitigation of sepsis-induced encephalopathy$593,428
R01 · FY2018 · NS
Causes, consequences, imaging and mitigation of sepsis-induced encephalopathy$593,428
R01 · FY2017 · NS
Causes, consequences, imaging and mitigation of sepsis-induced encephalopathy$576,124
R01 · FY2016 · NS
Development of quantitative imaging biomarkers for assessing response to sarcoma$264,223
U54 · FY2016 · CA · contact PI
Causes, consequences, imaging and mitigation of sepsis-induced encephalopathy$588,164
R01 · FY2015 · NS
Development of quantitative imaging biomarkers for assessing response to sarcoma$257,109
U54 · FY2015 · CA · contact PI
Development of quantitative imaging biomarkers for assessing response to sarcoma$267,525
U54 · FY2014 · CA · contact PI
Development of quantitative imaging biomarkers for assessing response to sarcoma$265,394
U54 · FY2013 · CA · contact PI
Development of quantitative imaging biomarkers for assessing response to sarcoma$278,853
U54 · FY2012 · CA · contact PI